Updated just now · Live
Stock analysis, price data, and AI-powered insights for Genprex Inc (GNPX).
Genprex Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for GNPX.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). GNPX Stock Intelligence Report. [stoxpulse.com/stocks/gnpx]
Disclaimer: The information on this page about Genprex Inc (GNPX) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Genprex Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Genprex Signs Sponsored Research Agreement to Stud...
11h ago
Genprex Research Collaborators Presents Preclinica...
1d ago
StoxPulse AI results for GNPX: Pulse Score 51.5/100. Primary sentiment trends from 6 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$10.4M
P/E Ratio
—
EPS
—
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
Genprex Research Collaborators Presents Preclinical Data From Studies Of Lead Drug Candidate, Reqorsa Gene Therapy For Treatment Of Lung Cancer At 2026 AACR Annual Meeting
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
Genprex : AACR 2026 Poster - TROP2 and PTEN are biomarkers of primary resistance to TUSC2 gene therapy in non-small cell lung cancer (NSCLC)
Genprex : AACR 2026 Poster - Quaratusugene Ozeplasmid Mediated TUSC2 Upregulation In EML4-ALK Bearing Non-small Cell Lung Carcinoma Induces Apoptosis And Is Highly Effective In Preclinical Studies
Genprex : AACR 2026 Poster - Restoring TUSC2 function boosts NK cell cytotoxicity and antitumor immunity in vivo and in vitro